Company Search:
Advanced Search
Sponsored Links
Zhenxing Biopharmaceutical & Chemical Inc Company Snapshot
Zhenxing Biopharmaceutical & Chemical Inc operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhenxing Biopharmaceutical & Chemical Inc with three other companies in this sector in China: Shenzhen Kangtai Biological Products Co Ltd (2015 sales of 452.51 million Chinese Renmimbi [US$65.84 million] ), Jiangxi Boya Bio-Pharmaceutical Co Ltd (543.10 million Chinese Renmimbi [US$79.02 million] of which 63% was Blood Plasma), and Pulike Biological Engineering Inc (478.01 million Chinese Renmimbi [US$69.55 million] of which 77% was Animal Biological Products).

Sales Analysis. During the year ended December of 2015, sales at Zhenxing Biopharmaceutical & Chemical Inc were 500.27 million Chinese Renmimbi (US$72.79 million). This is an increase of 2.2% versus 2014, when the company's sales were 489.49 million Chinese Renmimbi. This was the fourth straight year of sales growth at Zhenxing Biopharmaceutical & Chemical Inc. The sales level in 2015 was fairly close to the level five years ago: in 2010, Zhenxing Biopharmaceutical & Chemical Inc had sales of 545.67 million Chinese Renmimbi. Sales of Other Industry saw an increase that was more than double the company's growth rate: sales were up 109.8% in 2015, from 2.32 million Chinese Renmimbi to 4.86 million Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Zhenxing Biopharmaceutical & Chemical Inc
  Stock Performance Chart for Zhenxing Biopharmaceutical & Chemical Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 32.87
(Figures in Chinese Renmimbi)
1 Week 2.1%   13 Weeks 5.8%  
4 Weeks -3.7%   52 Weeks 15.0%  
Zhenxing Biopharmaceutical & Chemical Inc Key Data:
  Ticker: 000403 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 500,269,283
(Year Ending Jan 2016).
Employees: 706
  Currency: Chinese Renmimbi Market Cap: 8,959,625,679
  Fiscal Yr Ends: December Shares Outstanding: 272,577,599
  Share Type: A Gu Closely Held Shares: 72,511,064
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.